CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley Adjusts Price Target on Incyte to $104 From $103, Maintains Equalweight Rating

Neutral
AI Analysis

Summary

Morgan Stanley adjusted its price target on Incyte to $104 from $103 while maintaining an Equalweight rating, representing a minimal change in valuation.

Importance:2/10
Sentiment:
0.00
price_targetanalyst_noterating_maintained
Related Companies

Read the original article

Published by yahoo_finance on July 22, 2026 12:54 PM

Read Original